On the other hand, enrichment for active NK cells in primary NB as defined by expression of immediate-early genes, including ZPF36, NR4A2, JUNB, FOS, FOSB, and CD69 was associated with improved outcome, but this significance did not hold true when the data were separated by risk group and MYCN status [92]. The gene discussed is MYCN; the disease is neuroblastoma.